Clinical Trial

Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 1, 2024 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Systematic evaluation of the value of molecular residual lesions of cervical cancer based on circulating tumor HPV in the prognostic evaluation and recurrence monitoring of cervical cancer patients.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06456112
Lead Sponsor Anhui Provincial Hospital
Conditions Cervical Cancer
Enrollment 83 participants
Start Date 2024-07-01
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-01